Cargando…

Recurrent posterior fossa group A (PFA) ependymoma in a young child with constitutional mismatch repair deficiency (CMMRD)

Detalles Bibliográficos
Autores principales:	Briggs, Mayen, Das, Anirban, Firth, Helen, Levine, Adrian, Sánchez‐Ramírez, Santiago, Negm, Logine, Ercan, Ayse B., Chung, Jill, Bianchi, Vanessa, Jalloh, Ibrahim, Phyu, Poe, Thorp, Nicky, Grundy, Richard G., Hawkins, Cynthia, Trotman, Jamie, Tarpey, Patrick, Tabori, Uri, Allinson, Kieren, Murray, Matthew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099894/ https://www.ncbi.nlm.nih.gov/pubmed/36341503 http://dx.doi.org/10.1111/nan.12862

Ejemplares similares

Immune Checkpoint Inhibition as Primary Adjuvant Therapy for an IDH1-Mutant Anaplastic Astrocytoma in a Patient with CMMRD: A Case Report—Usage of Immune Checkpoint Inhibition in CMMRD
por: Rittberg, Rebekah, et al.
Publicado: (2021)

Role of video capsule endoscopy in patients with constitutional mismatch repair deficiency (CMMRD) syndrome: report from the International CMMRD Consortium
por: Shimamura, Y., et al.
Publicado: (2018)

EPEN-13. PATTERN OF RELAPSE IN POSTERIOR FOSSA EPENDYMOMA GROUP A
por: Bajin, Inci Yaman, et al.
Publicado: (2023)

EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression
por: Antin, C., et al.
Publicado: (2020)

Diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma
por: Pratt, Drew, et al.
Publicado: (2020)

EPEN-03. USP7 is an interaction partner of EZHIP and potential druggable target in PFA ependymomas
por: Jenseit, Anne, et al.
Publicado: (2022)

Treatment implications of posterior fossa ependymoma subgroups
por: Ramaswamy, Vijay, et al.
Publicado: (2016)

EPEN-08. THE TREM1 POSITIVE HYPOXIC MYELOID SUBPOPULATION IN POSTERIOR FOSSA EPENDYMOMA
por: Willard, Nicholas, et al.
Publicado: (2021)

Report of the fifth meeting of the European Consortium 'Care for CMMRD' (C4CMMRD), Leiden, The Netherlands, July 6th 2019
por: Suerink, M., et al.
Publicado: (2020)

Embryonal tumor with multilayered rosettes: Overview of diagnosis and therapy
por: Chadda, Karan R, et al.
Publicado: (2023)

EPEN-11. TUMOR DIFFERENTIATION IMPACTS THE BIOLOGY OF RECURRENCE IN CHILDHOOD POSTERIOR FOSSA EPENDYMOMA
por: Donson, Andrew, et al.
Publicado: (2021)

EPEN-26. NON-CANONICAL NF-κB SIGNALING DRIVES MESENCHYMAL EPENDYMAL CELL SUBPOPULATION IN PFA EPENDYMOMA
por: Griesinger, Andrea, et al.
Publicado: (2020)

Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways
por: Pun, Matthew, et al.
Publicado: (2023)

Characterization of global 5-hydroxymethylcytosine in pediatric posterior fossa ependymoma
por: Wu, Tao, et al.
Publicado: (2020)

Delineation of molecular characteristics in pediatric PFA ependymoma involving rare osseous and pulmonary metastases: A case report and literature review
por: Zhou, Mading, et al.
Publicado: (2022)

Autopsy findings of previously described case of diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma
por: Alturkustani, Murad, et al.
Publicado: (2021)

EPEN-08. COMBINED PDGFR INHIBITOR AXITINIB AND RETINOID TRETINOIN DECREASES PROLIFERATION AND HIGH-RISK NEOPLASTIC SUBPOPULATION PROPORTIONS PFA EPENDYMOMA
por: Donson, Andrew, et al.
Publicado: (2023)

CMMRD caused by PMS1 mutation in a sudanese consanguineous family
por: Hamad, Reem S., et al.
Publicado: (2022)

The NHS England 100,000 Genomes Project: feasibility and utility of centralised genome sequencing for children with cancer
por: Trotman, Jamie, et al.
Publicado: (2022)

SOFTWARE DESIGN FOR PFA TOOLS
por: Thomson, M.
Publicado: (2012)

IMG-13. MRI-BASED RADIOMICS PROGNOSTIC MARKERS OF POSTERIOR FOSSA EPENDYMOMA
por: Tam, Lydia, et al.
Publicado: (2020)

Sacral ependymoma presents 20 years after initial posterior fossa lesion
por: Nicely, Lynden Guy, et al.
Publicado: (2023)

PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism
por: Jain, Siddhant U., et al.
Publicado: (2019)

HGG-40. NF1 mosaicism in a CMMRD-patient with a glioblastoma
por: Guerrini-Rousseau, Lea, et al.
Publicado: (2022)

EZHIP: a new piece of the puzzle towards understanding pediatric posterior fossa ependymoma
por: Jenseit, Anne, et al.
Publicado: (2021)

Pediatric ependymomas: destined to recur?
por: Ritzmann, Timothy A, et al.
Publicado: (2021)

Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features – a retrospective analysis of the HIT ependymoma trial cohort
por: Jünger, Stephanie T., et al.
Publicado: (2019)

EPEN-06. CELL ECOSYSTEM AND SIGNALING PATHWAYS OF PRIMARY AND METASTATIC PEDIATRIC POSTERIOR FOSSA EPENDYMOMA
por: Aubin, Rachael, et al.
Publicado: (2021)

Pro-inflammatory cytokines mediate the epithelial-to-mesenchymal-like transition of pediatric posterior fossa ependymoma
por: Aubin, Rachael G., et al.
Publicado: (2022)

EPEN-30. 5FU with Radiation Followed by Maintenance of 5FU and ATRA Significantly Improves Survival of 1q+/6q- PFA Ependymoma Xenograft Models
por: Grimaldo, Enrique, et al.
Publicado: (2022)

Application of PFA tools to sLHC detectors
por: Ruan, M.
Publicado: (2015)

Early Colorectal Cancers Provide New Evidence for a Lynch Syndrome-to-CMMRD Phenotypic Continuum
por: Fernández-Rozadilla, Ceres, et al.
Publicado: (2019)

HGG-26. GENOMIC AND IMMUNE ANALYSIS OF PRIMARY REPLICATION-REPAIR DEFICIENT (RRD) GLIOMAS REVEALS THREE SUBGROUPS WITH DISTINCT DRIVERS AND RESPONSE TO IMMUNOTHERAPY: AN IRRDC REPORT
por: Fernandez, Nicholas R, et al.
Publicado: (2023)

Tissue sparing surgery in knee reconstruction: unicompartmental (UKA), patellofemoral (PFA), UKA + PFA, bi-unicompartmental (Bi-UKA) arthroplasties
por: Confalonieri, N., et al.
Publicado: (2008)

Identification of key methylation differentially expressed genes in posterior fossa ependymoma based on epigenomic and transcriptome analysis
por: Wang, Guanyi, et al.
Publicado: (2021)

Posterior fossa ependymoma H3 K27-mutant: an integrated radiological and histomolecular tumor analysis
por: Mariet, Cassandra, et al.
Publicado: (2022)

OMIC-08. COMPOUND HETEROZYGOSITY OF POLE AND PMS2 LEADS TO CMMRD-LIKE PHENOTYPE- “POLYNCH” SYNDROME
por: Michaeli, Orli, et al.
Publicado: (2021)

Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma
por: Tabori, U, et al.
Publicado: (2008)

Validation of the new pathology staging system for progressive supranuclear palsy
por: Briggs, Mayen, et al.
Publicado: (2021)

Impairment of intellectual functions after surgery and posterior fossa irradiation in children with ependymoma is related to age and neurologic complications
por: von Hoff, Katja, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_bg2cq4mb98jmq3ag7sh4571jnv